Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment

被引:16
作者
Kleinauskiene, Rita [1 ]
Jonkaitiene, Regina [1 ]
机构
[1] Hosp Lithuanian Univ Hlth Sci, Med Acad, Dept Cardiol, Eiveniu G 2, LT-50161 Kaunas, Lithuania
来源
MEDICINA-LITHUANIA | 2018年 / 54卷 / 02期
关键词
degenerative aortic stenosis; lipoproteins; dyslipidemia; statins; medical treatment; LIPID-LOWERING THERAPY; VALVE DISEASE; LIPOPROTEIN(A) LEVELS; RAPID PROGRESSION; RISK-FACTORS; CALCIFICATION; ASSOCIATION; SIMVASTATIN; MECHANISMS; MANAGEMENT;
D O I
10.3390/medicina54020024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Degenerative aortic stenosis (DAS) is the most frequently diagnosed heart valve disease in Europe and North America. DAS is a chronic progressive disease which resembles development of atherosclerosis. Endothelial dysfunction, lipid infiltration, calcification and ossification are evidenced in both diseases. The same risk factors such as older age, male sex, smoking, and elevated levels of lipids are identified. The effect of smoking, visceral obesity, metabolic syndrome, hypercholesterolemia, low-density lipoprotein, high-density lipoprotein, lipoprotein(a), adiponectin and apolipoprotein(a) on development of DAS are being studied. The search for genetic ties between disorders of lipid metabolism and DAS has been started. DAS is characterized by a long symptom-free period which can last for several decades. Aortic valve replacement surgery is necessary when the symptoms occur. The lipid-lowering therapy effect on stopping or at least slowing down the progression of DAS was studied. However, the results of the conducted clinical trials are controversial. In addition, calcium homeostasis, bone metabolism and calcinosis-reducing medication are being studied. Although prospective randomized clinical trials have not demonstrated any positive effect of statins used for slowing progression of the disease, statins are still recommended for patients with dyslipidemia. Recent study has suggested that a specific modification of treatment, based on severity of disease, may have a beneficial effect in patients with aortic sclerosis and mild DAS. New clinical studies analyzing new treatment possibilities which could correct the natural course of the disease and reduce the need for aortic valve replacement by surgery or transcatheter treatment interventions are needed.
引用
收藏
页数:11
相关论文
共 55 条
[1]   Intraleaflet haemorrhage is associated with rapid progression of degenerative aortic valve stenosis [J].
Akahori, Hirokuni ;
Tsujino, Takeshi ;
Naito, Yoshiro ;
Matsumoto, Mika ;
Lee-Kawabata, Masaaki ;
Ohyanagi, Mitsumasa ;
Mitsuno, Masataka ;
Miyamoto, Yuji ;
Daimon, Takashi ;
Hao, Hiroyuki ;
Hirota, Seiichi ;
Masuyama, Tohru .
EUROPEAN HEART JOURNAL, 2011, 32 (07) :888-896
[2]   Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis [J].
Andersson, Charlotte ;
Abdulla, Jawdat .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (01) :21-27
[3]  
[Anonymous], 2016, EUROPEAN HEART J, DOI [DOI 10.1093/eurheartj/ehw272, 10.1093/eurheartj/ehw272]
[4]   Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort [J].
Arsenault, Benoit J. ;
Boekholdt, S. Matthijs ;
Dube, Marie-Pierre ;
Rheaume, Eric ;
Wareham, Nicholas J. ;
Khaw, Kay-Tee ;
Sandhu, Manjinder S. ;
Tardif, Jean-Claude .
CIRCULATION-CARDIOVASCULAR GENETICS, 2014, 7 (03) :304-310
[5]  
Baumgartner H, 2018, EUR HEART J, V39, P1980, DOI [10.1093/eurheartj/ehx636, 10.1093/eurheartj/ehx391]
[6]  
Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]
[7]   Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals The Multi-Ethnic Study of Atherosclerosis [J].
Cao, Jing ;
Steffen, Brian T. ;
Budoff, Matthew ;
Post, Wendy S. ;
Thanassoulis, George ;
Kestenbaum, Bryan ;
McConnell, Joseph P. ;
Warnick, Russell ;
Guan, Weihua ;
Tsai, Michael Y. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (05) :1003-1009
[8]   Impact of Metabolic Syndrome on Progression of Aortic Stenosis Influence of Age and Statin Therapy [J].
Capoulade, Romain ;
Clavel, Marie-Annick ;
Dumesnil, Jean G. ;
Chan, Kwan L. ;
Teo, Koon K. ;
Tam, James W. ;
Cote, Nancy ;
Mathieu, Patrick ;
Despres, Jean-Pierre ;
Pibarot, Philippe .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (03) :216-223
[9]   Aortic stenosis: insights on pathogenesis and clinical implications [J].
Carita, Patrizia ;
Coppola, Giuseppe ;
Novo, Giuseppina ;
Caccamo, Giuseppa ;
Guglielmo, Marco ;
Balasus, Fabio ;
Novo, Salvatore ;
Castrovinci, Sebastiano ;
Moscarelli, Marco ;
Fattouch, Khalil ;
Corrado, Egle .
JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (06) :489-498
[10]   Aortic Stenosis: Pathophysiology, Diagnosis, and Medical Management of Nonsurgical Patients [J].
Cary, Theresa ;
Pearce, Judith .
CRITICAL CARE NURSE, 2013, 33 (02) :58-72